Tag: pharmacodynamic
Biocon confident of resolving issues with USFDA over biosimilar ‘pegfilgrastim’
While the company is set to launch proposed biosimilar, Pegfilgrastim in the United States market, the US Food and Drug Administration has issued Complete Response Letter (CRL) to it seeking more data on the cancer drug..............